GlassScriptPhysician profile
Cheryl Grumbach
NPI 1831292770
$1,394.21
in general payments reported to CMS, 2019-2025
17 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $280 · 2022: $377 · 2023: $249 · 2024: $371 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $305.64 | 2021-2023 | Repatha |
| Boston Scientific Corporation | $250.15 | 2023-2025 | Watchman Access System, Watchman Flx, Ingevity Mri |
| Novartis Pharmaceuticals Corporation | $182.82 | 2021-2024 | |
| Actelion Pharmaceuticals US, INC. | $122.10 | 2024 | Opsumit, Uptravi |
| Abbott Laboratories | $105.89 | 2021-2024 | Amplatzer Amulet |
| Regeneron Healthcare Solutions, INC. | $78.89 | 2025 | Evkeeza |
| Janssen Pharmaceuticals, INC | $58.33 | 2022-2024 | Xarelto |
| Pfizer INC. | $57.47 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $44.30 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.80 | 2024 | Lifevest |
| Biosense Webster, INC. | $34.18 | 2021 | |
| Medtronic, INC. | $32.25 | 2021-2024 | Azure Xt Dr Mri Surescan |
| Novo Nordisk INC | $22.51 | 2024 | Wegovy |
| Sobi, INC | $22.46 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $13.89 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akcea Therapeutics, INC. | $13.86 | 2021 | |
| Sanofi-Aventis U.S. LLC | $11.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Grumbach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.